Press

Newsroom

Contact
press@imprimedicine.com
Follow
Download
Press Kit

Featured articles

ImpriMed is Revolutionizing Canine Cancer Treatment with Precision and Personalization
SynBioBeta

How ImpriMed Turned Nine Years in Veterinary Oncology Into a Human Blood Cancer Business

Read More →
ImpriMed is Revolutionizing Canine Cancer Treatment with Precision and Personalization
TechCrunch

Dog cancer treatment ImpriMed aims to expand its AI technology into human oncology

Read More →
ImpriMed is Revolutionizing Canine Cancer Treatment with Precision and Personalization
USA Today

ImpriMed’s Transformative, Personal Approach to Canine Cancer Treatment

Read More →
Meet ImpriMed, Mayo Clinic just welcomed to its AI accelerator program
MedCity News

Meet the 7 startups Mayo Clinic just welcomed to its AI accelerator

Read More →

Latest Stories

Button Text
In the News
Button Text
Presentations
Button Text
Press Releases
Button Text
Scientific Publications
Button Text
Video/Podcast Interviews
Video/Podcast Interviews
Rodrigo Flamenco Logo

Interview with Sungwon Lim: Founder & CEO of ImpriMed

Entrepreneurship, Interviews, Level Up!
Learn More →
Presentations
NYC Oncology Conference 2019

ImpriMed: precision medicine for pet cancer care

NYC Oncology Conference 2019
Learn More →
Presentations
Veterinary Cancer Society Logo

Individualizing chemotherapy for canine lymphoma based on ex vivo drug sensitivity test

Veterinary Cancer Society Annual Conference 2019
Learn More →
Press Releases
GlobeNewswire Logo

ImpriMed Raises $4M for Customized Cancer Treatments for Dogs

GlobeNewswire
Learn More →
In the News
Tech crunch logo

At Pear demo day, a who’s who of VCs, and plenty of fresh ideas

TechCrunch
Learn More →